Literature DB >> 28450663

Epidemiology of Myocardial Infarction Caused by Presumed Paradoxical Embolism via a Patent Foramen Ovale.

Franz X Kleber1, Telse Hauschild2, Antonia Schulz1, Anne Winkelmann3, Leonhard Bruch3.   

Abstract

BACKGROUND: Despite several negative prospective randomized trials on the efficacy of patent foramen ovale (PFO) occlusion, the discussion on indications is ongoing. Because the incidence of paradoxical coronary embolism through a PFO is unknown, we investigated the risk of paradoxical embolic myocardial infarction over a period of 13 years.Methods and 
Results: We conducted a retrospective and a prospective study. In the former, we searched the hospital database of a tertiary referral center for cases of acute myocardial infarction (AMI) during the past 10 years and screened them for possible paradoxical MIs. On this basis we started a prospective evaluation over 39 months in another tertiary referral center. All patients with AMI and normal coronary arteries were screened for PFO and if no other reason for the AMI could be found, the case was judged as presumed paradoxical embolism. In the retrospective analysis we found 22 cases (0.45%) of presumed paradoxical coronary artery embolism under 4,848 AMI. In the prospective study there were 11 presumed paradoxical coronary artery embolisms among 1,654 patients with AMI, representing an incidence of 0.67%.
CONCLUSIONS: Our findings demonstrated that well below 1% of AMIs are caused by paradoxical embolism via an interatrial communication. Although this percentage appears low, it is not a negligible number of patients based on the huge number of MIs occurring in the industrialized world.

Entities:  

Keywords:  Myocardial infarction; Paradoxical embolism; Patent foramen ovale

Mesh:

Year:  2017        PMID: 28450663     DOI: 10.1253/circj.CJ-16-0995

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  7 in total

Review 1.  Simultaneous acute cardio-cerebral infarction: is there a consensus for management?

Authors:  Oluwaseun A Akinseye; Muhammad Shahreyar; Mark R Heckle; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2018-01

2.  Serpentine thrombus in the heart: a rare case of trapped thrombus in patent foramen ovale.

Authors:  Dominika M Zoltowska; Yashwant Agrawal; Jagadeesh K Kalavakunta
Journal:  BMJ Case Rep       Date:  2018-03-21

Review 3.  Patent Foramen Ovale Closure in 2019.

Authors:  Joel P Giblett; Omar Abdul-Samad; Leonard M Shapiro; Bushra S Rana; Patrick A Calvert
Journal:  Interv Cardiol       Date:  2019-02

4.  Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report.

Authors:  Taku Yasui; Yohei Okuda; Wataru Shioyama; Toru Oka; Tatsuya Nishikawa; Risa Kamada; Koji Hatano; Kazuo Nishimura; Masashi Fujita
Journal:  Cardiooncology       Date:  2020-09-07

Review 5.  Cardio-cerebral infarction in left MCA strokes: a case series and literature review.

Authors:  Elochukwu Ibekwe; Hera A Kamdar; Tamara Strohm
Journal:  Neurol Sci       Date:  2021-09-29       Impact factor: 3.830

6.  Cardiac magnetic resonance imaging unmasks presumed embolic myocardial infarction due to patent foramen ovale case report.

Authors:  Kate Liang; Matthew Williams; Chiara Bucciarelli-Ducci
Journal:  Eur Heart J Case Rep       Date:  2022-02-01

7.  Rare Source of Embolism in a Young Patient: Case Report and Literature Review.

Authors:  Marianna Vachalcová; Monika Jankajová; Marta Jakubová; Karolina Angela Sieradzka; Tibor Porubän; Gabriel Valočik; Peter Šafár; Daniela Ondušová; Ján Petruš; Ingrid Schusterová
Journal:  J Clin Med       Date:  2022-04-05       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.